Related by context. All words. (Click for frequent words.) 72 chemotherapeutics 71 chemotherapeutic agents 70 chemotherapeutic drug 70 chemotherapeutic drugs 68 alkylating agent 67 chemotherapies 67 chemotherapeutic agent 67 cytotoxic 67 cytotoxic agents 67 cytostatic 67 anticancer agents 66 etoposide 66 proteasome inhibitors 66 molecularly targeted 66 antitumor 66 chemotherapeutic regimens 65 anticancer drugs 65 anticancer therapy 65 vinca alkaloids 65 anticancer therapies 65 relapsed ovarian cancer 65 Irinotecan 65 erlotinib Tarceva ® 65 EGFR tyrosine kinase inhibitors 65 novel peptide 65 chemotherapy regimens 64 xenograft models 64 antimetabolite 64 cytotoxic chemotherapy 64 EGFR inhibitors 64 superficial bladder cancer 64 HSP# inhibitor 64 antiangiogenesis 64 immunomodulatory 64 taxane chemotherapy 64 taxane therapy 63 imatinib Gleevec 63 tyrosine kinase inhibitors 63 MEK inhibitors 63 predictive biomarkers 63 Doxorubicin 63 taxanes 63 paclitaxel Taxol 63 anti angiogenic 63 virotherapy 63 proteasome inhibitor 63 cardiotoxic 63 conventional chemotherapies 63 DFMO 63 Gefitinib 63 taxane 63 imatinib Gleevec ® 63 protein kinase inhibitor 63 nucleoside analogs 62 bortezomib Velcade 62 Gleevec resistant 62 tyrosine kinase inhibitor 62 immunosuppressive regimens 62 bevacizumab Avastin ® 62 Cisplatin 62 antitumoral 62 trans retinoic acid ATRA 62 dasatinib Sprycel 62 kinase inhibition 62 BRAF inhibitors 62 immune stimulatory 62 doxorubicin HCl 62 TKI therapy 62 CBLC# 62 OMP #M# 62 idarubicin 62 immune modulating 62 JAK2 inhibitors 62 histone deacetylase inhibitor 62 pegfilgrastim 62 docetaxel Taxotere 62 talabostat 62 radioprotective 62 chemotherapeutic treatments 62 chemopreventive agents 62 humanized antibody 62 camptothecin 62 standard chemotherapy regimens 62 anti angiogenic agent 62 anti angiogenic drugs 62 VEGF inhibitors 62 gemcitabine Gemzar 61 lapatinib Tykerb 61 receptor tyrosine kinase inhibitor 61 selective inhibition 61 EGF receptor 61 antiangiogenic 61 seliciclib 61 epirubicin 61 Erlotinib 61 ENMD # 61 PARP inhibitors 61 vinca alkaloid 61 chemopreventive 61 dasatinib Sprycel ® 61 busulfan 61 depsipeptide 61 bendamustine 61 fluoropyrimidine 61 TKIs 61 trastuzumab Herceptin ® 61 liposomal formulation 61 solid tumors 61 cytotoxicity 61 cisplatin 61 peptide antigens 61 Etoposide 61 immunomodulator 61 bevacizumab Avastin 61 preclinically 61 antitumor effect 61 therapeutic regimens 61 DACH platinum 61 antiangiogenic agents 61 thalidomide Thalomid 61 EGFR pathway 61 anti leukemic 61 azacytidine 61 potent antiproliferative 61 anticancer agent 61 humanized monoclonal antibodies 61 HER2 positive metastatic breast 61 radionuclide therapy 61 erythropoietic 60 5 fluorouracil 60 anti tubercular 60 cleavable linker 60 TACE 60 endocrine therapies 60 anticancer 60 antithrombotic 60 Fludarabine 60 microtubule targeting 60 cytotoxics 60 PI3K inhibitors 60 multitargeted 60 irinotecan chemotherapy 60 inhibiting tumor 60 anti angiogenic agents 60 Doxil ® 60 MMP inhibitors 60 AKT inhibitor 60 vorinostat 60 trabectedin 60 Trastuzumab 60 lenalidomide dexamethasone 60 MGd 60 tumor necrosis 60 radiolabeled antibodies 60 metastatic renal cell carcinoma 60 antiangiogenic agent 60 siRNA therapeutics 60 immunotoxin 60 5FU 60 metastatic RCC 60 Gemcitabine 60 antisense oligonucleotides 60 adenoviral 60 docetaxel chemotherapy 60 albumin bound paclitaxel 60 trastuzumab Herceptin 60 hematological cancers 60 anti mitotic 60 rifamycins 60 overlapping toxicities 60 nilotinib Tasigna ® 60 bleomycin 60 sorafenib Nexavar 60 pegylated liposomal doxorubicin 60 CA4P 60 immunotoxins 60 PROCHYMAL 60 IAP inhibitor 60 small molecule tyrosine 60 potent cytotoxic 60 CD# expressing 60 antifungal therapy 60 cytoprotective 60 molecularly targeted therapies 60 Platinol ® cisplatin 60 neoadjuvant chemotherapy 60 Carfilzomib 60 OncoVEX GM CSF 60 hormonal therapies 60 NEUGENE 60 immunosuppressant 60 gemcitabine 60 immunomodulation 60 immune modulatory 60 imatinib mesylate 60 oncolytic 60 small molecule inhibitors 60 endostatin 60 nucleoside analog 60 Bortezomib 60 radiolabeled 60 Zalypsis 60 calcineurin inhibitors 60 nucleosides 60 amikacin 59 anti angiogenic therapy 59 vinblastine 59 Anthracycline 59 tumor vascular disrupting 59 gefitinib Iressa 59 HGS# 59 multi kinase inhibitor 59 antiangiogenic therapy 59 chemotherapy docetaxel 59 antimetastatic 59 enzyme inhibitor 59 acute GvHD 59 alkylating agents 59 doublet chemotherapy 59 mycophenolate mofetil 59 cytotoxic therapies 59 angiogenesis inhibitor 59 personalized immunotherapy 59 microtubule inhibitor 59 UsiRNAs 59 IgG1 antibody 59 tyrosine kinase inhibitor TKI 59 immunomodulating 59 cisplatin resistant 59 IMA# 59 oral antiviral 59 ganciclovir 59 topotecan 59 ELACYT 59 immunomodulatory therapy 59 doxorubicin 59 cisplatin carboplatin 59 Preclinical studies suggest 59 investigational therapies 59 humanised monoclonal antibody 59 viral kinetics 59 EndoTAGTM 1 59 echinocandins 59 Aplidin 59 immune modulator 59 paclitaxel Taxol ® 59 erlotinib Tarceva 59 gemcitabine chemotherapy 59 pertuzumab 59 immunotherapeutic 59 FUSILEV enhances 59 mRCC 59 EndoTAG TM -1 59 Cytoxan 59 RNAi compounds 59 antineoplastic 59 Pertuzumab 59 cisplatin chemotherapy 59 Sorafenib 59 HCV protease inhibitors 59 chemotherapeutic regimen 59 chemoresistance 59 apoptosis inducing 59 aminoglycoside 59 5 FU 59 alkylating 59 antimitotic 59 huN# DM1 59 fibrinolytic 59 TNFa 59 chemosensitivity 59 therapies 59 oral prodrug 59 Smac mimetic 59 EGFR TKIs 59 Xanafide 59 IAP inhibitors 59 metastatic malignant melanoma 59 angiogenesis inhibition 59 HGS ETR1 59 anti proliferative 59 Panzem R NCD 59 EGFR TKI 59 enzyme inhibitors 59 targeted antifolate 59 antiviral therapies 59 PLX# 59 chemoradiotherapy 59 peritoneal carcinomatosis 59 sorafenib Nexavar ® 59 cilengitide 59 Symadex 59 estramustine 59 Hsp# inhibition 59 triphendiol 59 CXCR4 receptor 59 Squalamine 59 inhibitory effects 59 gemcitabine cisplatin 59 adriamycin 59 CYT# potent vascular disrupting 59 systemic antifungal 59 delafloxacin 59 vinorelbine 59 chemotherapy cisplatin 59 enzastaurin 59 oral JAK1 59 ISF# 59 NNRTIs 59 Interferon alpha 59 GAP #B# 58 interferon IFN 58 immunotherapy 58 immune suppressive 58 tigecycline 58 EGFr 58 kinase inhibitors 58 tumor antigens 58 AEG# 58 tyrosine kinase inhibitors TKIs 58 trans retinoic acid 58 Litx 58 radiotherapeutic 58 cetuximab Erbitux R 58 siRNA therapeutic 58 chemoresistant 58 AMN# [001] 58 BCG refractory 58 NEUGENE antisense 58 HuLuc# 58 intravesical instillation 58 Oxaliplatin 58 intravesical 58 monoclonal antibody therapies 58 azole 58 p# inhibitor 58 anti fibrotic 58 novel anticancer 58 bifunctional 58 CDDO Im 58 uric acid lowering 58 chemo resistant 58 cyclosporin 58 epithelial tumors 58 5 FU leucovorin 58 fulvestrant 58 imetelstat 58 vitamin D analogs 58 SCCHN 58 SERMs 58 photodynamic 58 metastatic malignant 58 Combination therapy 58 mTOR inhibitors 58 taxol 58 Mitoxantrone 58 resectable 58 anticancer activity 58 Anthracyclines 58 cyclophosphamide 58 bone metastasis 58 nucleoside analogues 58 bispecific antibodies 58 antiproliferative effects 58 morpholino 58 BRAF inhibitor 58 induce apoptosis 58 amrubicin 58 intratumoral injection 58 chemopreventive agent 58 Smac mimetics 58 mda 7 58 antiinflammatory 58 amphotericin B 58 bactericidal 58 ErbB3 HER3 58 Pegylated Interferon 58 peptide conjugated 58 PARP inhibitor 58 heavily pretreated patients 58 immuno modulatory 58 durable remissions 58 neoadjuvant therapy 58 regorafenib 58 mutational status 58 viral polymerase 58 immunosuppressive agents 58 immunotherapies 58 potentiator 58 Tamibarotene 58 LHRH 58 macrolide antibiotics 58 paclitaxel Taxol R 58 Cardiotoxicity 58 anti secretory 58 pancreatic adenocarcinoma 58 antibody fragment 58 metastatic neuroendocrine tumors 58 Pemetrexed 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 antiplatelet therapies 58 Surgical resection 58 Imatinib 58 vidofludimus 58 cediranib 58 colorectal cancer liver metastases 58 orally bioavailable 58 HDACi 58 IFN beta 58 arsenic trioxide 58 antiproliferative 58 chimeric monoclonal antibody 58 antibody mediated 58 TREANDA 58 Onconase 58 rifamycin 58 flavopiridol 58 antiviral therapy 58 radiation chemoradiation 58 myeloablative 58 potent anticancer 58 Fludara 58 tubulin binding 58 malignant lymphomas 58 mitomycin 58 lenalidomide Revlimid R 58 immunoconjugate 58 LE DT 58 Vidofludimus 58 Interferon beta 58 pentamidine 58 imatinib therapy 58 GW# [003] 58 Panzem NCD 58 liposomal doxorubicin 58 neuroregenerative 58 LHRH antagonists 58 inhibit viral replication 58 ganetespib 58 PRT# 58 taxane refractory 58 TLR8 agonist 58 cytotoxic effects 58 vascular disrupting agents 58 malignant pleural mesothelioma 58 Velcade bortezomib 58 inhibit replication 58 L asparaginase 58 prodrugs 58 irreversible inhibitor 58 colorectal liver metastases 58 panobinostat 58 vincristine 58 Dasatinib 58 Triapine 58 immune modulators 58 Paraplatin ® carboplatin 58 ESBA# 58 alvespimycin 58 immunomodulators 58 DHFR 58 Tyrima 58 metastatic bladder 58 Tarvacin 58 concurrent chemoradiation 58 #ME# 58 oxidative stress inducer 58 resistant ovarian cancer 58 PEG SN# 58 Telintra 58 DiLA2 58 histone deacetylase HDAC inhibitor 58 factor G CSF 58 Taxol ® 58 OXi# 58 photodynamic therapy 58 recombinant antibodies 58 ON #.Na 58 gastrointestinal stromal tumors GISTs 58 cetuximab Erbitux ® 58 hormone gastrin 57 #I TM# 57 delta isoform 57 bortezomib 57 hormone refractory 57 effector function 57 metastatic colorectal 57 antitumor activity 57 indibulin 57 BAL# [001] 57 anticancer compound 57 Annamycin 57 heavily pretreated 57 metaglidasen 57 interferon ribavirin 57 urothelial bladder cancer 57 integrin receptors 57 IGF IR 57 hyperthermia therapy 57 potent antibacterial 57 pharmacokinetic interactions 57 antitumor efficacy 57 photosensitizers 57 multikinase inhibitor 57 imexon 57 doxorubicin Adriamycin 57 nonviral 57 azoles 57 paclitaxel carboplatin 57 radiation sensitizer 57 interferons 57 lytic 57 5 Fluorouracil 57 kinase inhibitor 57 anthracycline containing 57 MAbs targeting 57 CHOP chemotherapy 57 CsA 57 vascular disrupting agent 57 BAY #-# 57 AQ4N 57 signal transduction inhibitors 57 GRN#L 57 Anticalins ® 57 Sym# 57 Fleximer 57 Aurora kinase 57 conventional DMARDs 57 exon skipping 57 HQK 57 cytotoxin 57 demonstrated antitumor activity 57 Darinaparsin 57 alpha interferon 57 FOLFOX chemotherapy 57 Bevacizumab 57 Nanobody 57 MDS AML 57 TTF Therapy 57 gastrointestinal stromal tumors GIST 57 stavudine d4T 57 differentiated thyroid 57 direct thrombin inhibitors 57 MetMAb 57 nanoviricide 57 heparanase 57 HDAC inhibitors 57 therapeutic monoclonal antibody 57 HCV protease 57 JAK2 inhibitor 57 Capecitabine 57 TLR9 agonist 57 trastuzumab 57 solubilizing 57 daunorubicin 57 Tarceva erlotinib 57 convenient dosing regimens 57 orally dosed 57 PEGylated 57 HGS ETR1 mapatumumab 57 biologic therapy 57 anticancer treatments 57 thrombopoietin 57 eflornithine 57 factor Xa inhibitor 57 insulin sensitizing 57 anti CD3 57 investigational humanized monoclonal antibody 57 pyrimethamine 57 platinum refractory 57 histone deacetylase inhibitors 57 drug zotarolimus 57 anti EGFR antibody 57 T#I [002] 57 Neulasta ® 57 Hsp# inhibitors 57 TG# [003] 57 FLT3 57 Gleevec imatinib 57 N acetylcysteine 57 NF kappaB activation 57 anionic backbone 57 chemotherapy hormonal therapy 57 polymerase inhibitors 57 Factor VIIa 57 XmAb# 57 Paraplatin ® 57 tegafur 57 postoperative chemotherapy 57 VAPRISOL 57 antitumour 57 beta lactams 57 Talabostat 57 mecamylamine 57 visilizumab 57 topical antimicrobial 57 Gliadel Wafer 57 CCX# 57 VEGFb 57 C. difficile toxins 57 cytoreduction 57 CYC# 57 alpha folate receptor 57 tolerogenic 57 IFN gamma 57 gemcitabine Gemzar ® 57 histone deacetylase HDAC inhibitors 57 Sphingomab 57 small molecule activators 57 T#I mutant 57 refractory chronic myeloid 57 dexamethasone Decadron 57 Fluorouracil 57 immunosuppressive therapies 57 Paclitaxel 57 TroVax ® 57 goserelin 57 cisplatin gemcitabine 57 Taxanes 57 targeted radiotherapeutic 57 alfa interferon 57 KIT mutations 57 milatuzumab 57 intravenously administered 57 neuroprotectant 57 iron chelators 57 obatoclax 57 fibrotic disease 57 neurotrophic 57 AMPK activators 57 myeloma cells 57 Chemophase 57 pyrazinamide 57 NF kB pathway 57 Seliciclib 57 pro apoptotic 57 nanoviricides 57 fluorouracil 57 rituximab Rituxan 57 transgene expression 57 olaparib 57 AP# [003] 57 cMET 57 oncolytic virus 56 HGS ETR2 56 BCR ABL mutations 56 Voreloxin 56 JAK2 56 Bendamustine 56 Photodynamic therapy 56 undruggable 56 EZN 56 colon carcinoma 56 biologic therapies 56 rapamycin 56 anticancer therapeutics 56 alefacept 56 hematological malignancies 56 Cytotoxic 56 BCR ABL 56 antifolates 56 Epidermal Growth Factor Receptor 56 tumor subtypes 56 demethylating agents 56 Taxotere ® 56 HER2 overexpression 56 secretory diarrhea 56 mAbs 56 Apo2L 56 Cloretazine 56 Azedra 56 TRAIL induced apoptosis 56 nucleotide analogs 56 RNA antagonist 56 ErbB2 positive 56 c MET 56 proteins peptides 56 interferon alfa 56 protease inhibitor PI 56 mutated KRAS gene 56 carboplatin paclitaxel 56 refractory NSCLC 56 cidofovir 56 selective inhibitor 56 PI3K Akt 56 DOXIL 56 TNF alpha antagonist 56 immunosuppressive 56 treating neuropathic pain 56 imatinib resistance 56 sunitinib malate 56 targeting CD# 56 deacetylase inhibitors 56 imatinib 56 TLR agonists 56 antidiabetic 56 non nucleoside 56 act synergistically 56 carbohydrate compounds 56 neuropilin 56 pegylated 56 antiresorptive 56 nucleoside 56 bevacizumab Avastin R 56 PI3K inhibitor 56 chronic lymphocytic leukemia CLL 56 Bleomycin 56 IMGN# 56 signal transduction inhibitor 56 molecular biomarkers 56 inducing apoptosis 56 Th2 cytokines 56 antifolate 56 advanced metastatic renal 56 YONDELIS 56 prostanoid 56 recurrent glioblastoma multiforme 56 pro angiogenic 56 nanomolar 56 Mitomycin C 56 PDGF receptor 56 curative therapy 56 Cytarabine 56 Telatinib 56 dasatinib 56 liposome encapsulated 56 adecatumumab 56 Hedgehog inhibitor 56 radiolabeled TM# 56 oblimersen 56 phosphate S1P 56 Camptothecin 56 nab paclitaxel 56 ovarian carcinoma 56 metastatic cancers 56 cytotoxic compounds 56 synthase TS 56 hypofractionated 56 hormone deprivation 56 intravenous cyclophosphamide 56 selectively inhibited 56 lupus nephritis 56 ara C 56 synthetic retinoid 56 sodium stibogluconate 56 TAFA# 56 infusional 56 FOLFIRINOX 56 riociguat 56 CD# antibody [001] 56 glioblastoma multiforme GBM 56 cancer immunotherapies 56 Vectibix monotherapy 56 M2 subunit 56 disease modifying antirheumatic 56 pomalidomide 56 tumor antigen 56 IFN alpha 56 Cloretazine ® 56 androgen independent 56 interferon lambda 56 molecular abnormalities 56 biodegradable nanoparticles 56 histologies 56 chemotherapy 56 TNF inhibitor 56 octreotide 56 hormone LHRH antagonist 56 HDAC6 56 NXL# 56 Gleevec imatinib mesylate 56 adoptive immunotherapy 56 relapsed leukemia 56 radezolid 56 PXD# 56 neoadjuvant 56 dacarbazine 56 refractory AML 56 Nanobodies 56 mapatumumab 56 Anticalins 56 PNP inhibitor 56 Pazopanib 56 oncoproteins 56 inhibiting viral replication 56 EGFR HER2 56 anthracycline chemotherapy 56 liposomal 56 intra arterial chemotherapy 56 echinocandin 56 EphA2 56 biomarker identification 56 preoperative chemotherapy 56 combinability 56 microwave hyperthermia 56 Cyclophosphamide 56 DXL# 56 nucleotide analogue 56 BiTE 56 Angiolix 56 Xeloda capecitabine 56 recombinant erythropoietin 56 acute leukemias 56 zidovudine AZT 56 Allovectin 7 ® 56 Chemotherapy 56 ProLindac 56 amphotericin 56 corticosteroid dexamethasone 56 tumor vasculature 56 relapsed SCLC 56 Liposomal 56 FK# 56 TLR8 56 surgical debulking 56 immune modulation 56 mutant KRAS 56 decitabine 56 refractory metastatic 56 Nanobodies ® 56 topoisomerase II 56 DsiRNA 56 RGB # 56 radiochemotherapy 56 castrate resistant 56 U1 Adaptors 56 CTAP# Capsules 56 hedgehog pathway 56 PSMA ADC 56 pDCs 56 surrogate endpoint 56 antifibrotic 56 hepatic metastases 56 verteporfin 56 L dopa 56 gefitinib 56 Rituximab 56 K RAS 56 LNP formulations 56 TMP SMX 56 disease modifying 56 therapeutic modality 56 Enzastaurin 56 Tumor Necrosis Factor 56 Faslodex 56 anthracycline taxane 56 immunosuppressant drug 56 inhibit tumor 56 NS#/#A protease 56 anti angiogenic therapies 56 MAXY G# 56 Epirubicin 56 refractory ovarian cancer 56 Tarvacin TM 56 γ secretase 56 taxotere 56 Tacrolimus 56 A3 adenosine receptor 56 oral kinase inhibitor 56 PORxin TM 56 GMX# 56 Traficet EN 56 potentially hepatotoxic 56 gemcitabine carboplatin 56 metastatic lesions 56 Amplimexon 56 proteasome inhibitor bortezomib 56 recurrent NSCLC 56 basal cell carcinoma BCC 56 NexACT ® 56 PKCi 56 Bcr Abl mutations 56 interferon 56 protamine 56 Radilex 56 cytotoxic therapy 56 FGFR 56 cytarabine 56 systemic toxicity 56 LY# [003] 56 anti tumoral 56 Fibroblast Growth Factor Receptor 56 protease inhibitors PIs 56 Lodamin 56 Natalizumab 56 T#I mutation 56 PEGPH# 56 GM CSF 56 pharmacologic 56 MAPK pathway 56 Pathway Inhibitor 56 OncoVEX 56 antiandrogen 56 arsenic trioxide ATO 56 farletuzumab 56 adjuvant therapy 55 OHR/AVR# 55 anti VEGF 55 antiviral 55 Carboplatin 55 lipid lowering therapies 55 denileukin diftitox 55 topical ophthalmic 55 Sudhir Agrawal D.Phil 55 JAK#/JAK# 55 IGF 1R inhibitor 55 GIST tumors 55 Elotuzumab 55 recurrent GBM 55 ATIR 55 CoFactor 55 radiolabeled monoclonal antibody 55 Interferon alfa 55 glycopeptide 55 antibiotic regimens 55 synthetic analogues 55 pegylated interferons 55 entinostat 55 novel immunomodulatory 55 COPREXA ™ 55 cyclophosphamide chemotherapy 55 immunotherapeutic agent 55 temozolomide TMZ 55 CCR2 55 FluCide 55 Zolinza 55 beta lactam antibiotic 55 relapsed MM 55 MET amplification 55 apoptotic pathway 55 MAb 55 interferon therapy 55 antisense inhibitors 55 siRNA molecules 55 Temozolomide 55 sargramostim 55 Copegus ribavirin 55 SIR Spheres 55 transarterial chemoembolization 55 sulindac 55 nifurtimox 55 Cetuximab 55 Neuradiab 55 DMARD 55 liposomal amphotericin B 55 ixabepilone 55 JAK inhibitors 55 nutlin 55 blood clot dissolving 55 Bcr Abl inhibitors 55 GISTs 55 somatostatin receptors 55 cytoreductive nephrectomy 55 TRV# [001] 55 idiotype vaccine 55 Temsirolimus 55 neovascular diseases 55 androgen receptor AR 55 EGFR expressing 55 metastatic kidney 55 Docetaxel 55 irinotecan oxaliplatin 55 synthetic lethality 55 gastrin 55 RhuDex ® 55 immunotherapeutics 55 IFN ß 55 CR# vcMMAE 55 selective orally bioavailable 55 siRNA binds 55 temsirolimus 55 Taxotere docetaxel 55 docetaxel Taxotere ® 55 Lapatinib 55 PI3K/Akt pathway inhibitor 55 Octreotide 55 sunitinib Sutent ® 55 lymphatic mapping 55 preclinical xenograft models 55 potent inhibitors 55 radiofrequency ablation RFA 55 IMC A# 55 histone deacetylase 55 leucovorin 55 CEQ# 55 CYP#A# inhibitors 55 lipid nanoparticles 55 photosensitizer 55 FUS1 55 nanoparticle formulation 55 forskolin 55 Aurora kinase inhibitor 55 cranial irradiation 55 adeno associated viruses 55 immunological diseases 55 recurrent ovarian cancer 55 dose cytarabine 55 pharmacologic intervention 55 oral anticancer